TrialBritish journal of haematology2020

Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myeloma.

Diana Basali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.